Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Immunology of hepatitis B virus infections

  • 32 Accesses

  • 4 Citations

Summary

Acute or chronic hepatitis B virus infection is often associated with symptoms which are probably caused by immune complexes, such as vasculitis, glomerulonephritis and arthritis. The immune complexes found in such patients contain excessive viral proteins. The functions of these proteins and the immune response to them during various states of infection are discussed.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Brodersen M, Kühn HA (1979) Virushepatitis. Klinik, Funktionsdiagnostik und Prognose. In: Kühn HA, Wernze H (eds) Klinische Hepatologie. Thieme, Stuttgart, pp 6.39–6.58

  2. 2.

    Schmid M (1979) Virushepatitis. Klinik, Funktionsdiagnostik und Prognose. In: Kühn HA, Wernze H (eds) Klinische Hepatologie. Thieme, Stuttgart, pp 6.280–6.297

  3. 3.

    Blum HE, Stowring L, Figus A et al. (1983) Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium, and vascular elements by in situ hybridization. Proc Natl Acad Sci USA 80:6685–6688

  4. 4.

    Pasquinelli C et al. (1986) Hepatitis B virus DNA in mononuclear blood cells. A frequent event in hepatitis B surface antigen-positive and -negative patients with acute and chronic liver disease. J Hepatol 3:95–103

  5. 5.

    McKenna PJ, O'Brian JT, Scheinman HZ, Delaney WE, Pellecchia C, Lepore MJ (1971) Hepatitis and arthritis with hepatitis-associated antigen in serum and synovial fluid. Lancet 214–215

  6. 6.

    Brzosko WJ, Krawczynski K, Nazarewicz T, Morzycka M, Nowoslawski A (1974) Glomerulonephritis associated with hepatitis-B surface antigen immune complexes in children. Lancet II:477–481

  7. 7.

    Toda G, Ishimaru Y, Mayumi M, Oda T (1978) Infantile papular acrodermatitis (Gianotti's diesease) and intrafamilial occurrence of acute hepatitis B with jaundice: age dependency of clinical manifestations of hepatitis B virus infection. J Infect Dis 138:211–216

  8. 8.

    Prince AM, Trepo C (1971) Role of immune complexes involving SH antigen in pathogenenesis of chronic active hepatitis and polyarteritis nodosa. Lancet II:1309–1312

  9. 9.

    Hess G, Rossol S, Voth R, Weber KC, Meyer zum Büschenfelde K-H (1989) Modification of the immune response against hepatitis B virus by the human immunodeficiency virus. Rheumatol Int 9:175–179

  10. 10.

    Raimondo G, Burk RD, Lieberman HM, Muschek J, Hadziyannis S, Will H, Kew MC, Dusheiko GM, Shafritz DA (1988) Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma. Virology 166:103–112

  11. 11.

    Harrison TJ, Anderson MG, Murray-Lyon IM, Zuckerman AJ (1986) Hepatitis B virus DNA in the hepatocyte. A series of 160 biopsies. J Hepatol 2:1–10

  12. 12.

    Tokino T, Nagaya T, Nakamura T, Fukushige S, Murotsu T, Matsubara K (1987) Integration of hepatitis B virus (HBV)DNA into chromosomes and their HBV-mediated rearrangements. In: Robinson W, Koike K, Will H (eds) Hepadna viruses. Liss, New York, pp 287–301

  13. 13.

    Beasly RP, Hwang LY, Lin CC, Chien CS (1981) Hepatocellular carcinoma and HBV: a prospective study of 22,707 men in Taiwan. Lancet II:1129–1133

  14. 14.

    Tiollais P, Pourcel C, Dejean A (1985) The hepatitis B virus. Nature 317:489–495

  15. 15.

    Koshy R, Koch S, Freytag von Loringhoven A, Kahmann R, Murray K, Hofschneider PH (1983) Integration of hepatitis B virus DNA: evidence for integration in the single-stranded gap. Cell 34:215–223

  16. 16.

    Heermann K-H, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich WH (1984) Large surface proteins of hepatitis B virus containing the pre-S sequence. J Virol 52:396–402

  17. 17.

    Marquardt O, Heermann K-H, Seifer M, Gerlich WH (1987) Cell type specific expression of preS1 antigen and secretion of hepatitis B surface antigen. Postgrad Med J 63:41–50

  18. 18.

    Persing DH, Varmus HE, Ganem D (1987) The preS1 protein of hepatitis B virus is acylated at its amino terminus with myristic acid. J Virol 61:1672–1677

  19. 19.

    Stamm B, Gerlich W, Thomssen R (1980) Quantitative determination of antibody against hepatitis B surface antigen: measurement of its binding capacity. J Biol Stand 8:59–68

  20. 20.

    Alberti A, Cavalletto D, Pontisso P, Chemello L, Tagariello G, Belussi F (1988) Antibody response to pre-S2 and hepatitis B virus induced liver damage. Lancet I:1421–1424

  21. 21.

    Budkowska A, Dubreuil P, Capel F, Pillot J (1986) Hepatitis B virus pre-S gene-encoded antigenic specificity and anti-pre-S antibody: relationship between anti-pre-S response and recovery. Hepatology 6:360–368

  22. 22.

    Hellström U, Sylvan S, Kuhns M, Sarin V (1986) Absence of pre-S2 antibodies in natural hepatitis B virus infection. Lancet II:889–893

  23. 23.

    Klinkert M-Q, Theilmann L, Pfaff E, Schaller H (1986) Pre-S1 antigens and antibodies early in the course of acute hepatitis B virus infection. J Virol 58:522–525

  24. 24.

    Gerken G, Manns M, Gerlich WH, Hess G, Meyer zum Büschenfelde K-H (1987) PreS encoded surface proteins in relation to the major viral surface antigen in acute hepatitis B virus infections. Gastroenterology 92:1864–1868

  25. 25.

    Caredda F, De Franchis R, D'Arminio Monforte A, Vecchi M, Rossi E, Primignani M, Palla M, Dioguardi N (1982) Persistence of circulating HBs/Ag/IgM complexes in acute viral hepatitis type B: an early marker of chronic evolution. Lancet II:358–360

  26. 26.

    Biswas R, Gerlich W, Schober A, Thomssen R (1976) Bestimmung der Antikörper gegen Subtypen des Hepatitis-B-Oberflächenantigens (HBsAg). Zentralbl Bakteriol Mikrobiol Hyg [A] 235:310–315

  27. 27.

    Dienstag JL (1987) Concurrent hepatitis B surface antigen and antibody and the clonal selection theory of antibody diversity. Gastroenterology 93:899–904

  28. 28.

    Ibarra MZ, Mora I, Quiroga JA, Bartolomé J, La Banda F, Porres JC, Carreno V (1988) IgG and IgM autoantiidiotype antibodies against antibody to HBsAg in chronic hepatitis B. Hepatology 8:775–780

  29. 29.

    Jin Y, Shih, W-K, Alter HJ, Berkower I (1988) An oligoclonal human T cell line specific for HBsAg is restricted to MHC class I antigens and responds to soluble antigen and to endogenous HBsAg. In: Zuckerman AJ (ed) Viral hepatitis and liver disease. Liss, New York, pp 678–683

  30. 30.

    Bruß V, Gerlich WH (1988) Formation of transmembranous hepatitis B e antigen by cotranslational in vitro processing of the viral precore protein. Virology 163:268–275

  31. 31.

    Garcia PD, Ou JH, Rutter WJ, Walter P (1988) Targeting of hepatitis B virus precore protein to the endoplasmatic reticulum membrane: after signal peptide cleavage translocation can be aborted and the product released into the cytoplasm. J Cell Biol 106:1093–1104

  32. 32.

    Schlicht HJ, Salfeld J, Schaller H (1987) The duck hepatitis B virus pre-C region encodes a signal sequence which is essential for synthesis and secretion of processed core proteins but not for virus formation. J Virol 61:3701–3709

  33. 33.

    Chang C, Enders G, Sprengel R, Peters N, Varmus HE, Ganem D (1987) Expression of the precore region of an avian hepatitis B virus is not required for viral replication. J Virol 61:3322–3325

  34. 34.

    Twu J-S, Lee C-H, Lin P-M, Schloemer RH (1988) Hepatitis B virus suppresses expression of human β-interferon. Proc Natl Acad Sci USA 85:252–256

  35. 35.

    Milich DR, McLachlan A (1986) The nucleocapsid of hepatitis B virus is both a T cell-independent and a T cell-dependent antigen. Science 234:1398–1401

  36. 36.

    Clarke BE, Carroll AR, Francis MJ, Appleyard G, Syred AD, Highfield PE, Rowlands DJ, Brown F, Newton SE (1988) Chimeric proteins based on hepatitis-B core antigen form highly immunogenic particles. In: Ginsberg H, Brown F, Lerner RA, Chanock RM (eds) Vaccines. Cold Spring Harbor Laboratory, New York, pp 127–131

  37. 37.

    Pignatelli M, Waters J, Lever A, Iwarson S, Gerety R, Thomas HC (1987) Cytotoxic T cell responses to the nucleocapsid proteins of HBV in chronic hepatitis. J Hepatol 4:15–21

  38. 38.

    Sells MA, Zelent AZ, Shvartsman M, Acs G (1988) Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J Virol 62:2836–2844

  39. 39.

    Sugiura S, Mizokami M, Orito E, Ina S, Kameshima N, Tanaka Y, Ogino M, Yamamoto M, Akaza T (1988) DR locus-inclusive HLA in patients with persistent hepatitis B surface antigen. In: Zuckerman AJ (ed) Viral hepatitis and liver disease. Liss, New York

  40. 40.

    Celis E, Kato I, Miller RW, Chang TW (1985) Regulation of the human immune response to HBsAg: effects of antibodies and antigen conformation in the stimulation of helper T cells by HBsAg. Hepatology 5:744–751

  41. 41.

    Neurath AR, Kent SBH, Strick N, Parker K (1986) Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46:429–436

  42. 42.

    Milich DR, McLachlan A, Thornton GB, Hughes JL (1987) Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature 239:547–549

  43. 43.

    Gerlich WH, Heermann KH, Thomssen R (1988) Wege zu einem optimalen Impfstoff gegen Hepatitis B Viren. Immun Infekt 16:167–174

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Heermann, K.-., Gerlich, W.H. Immunology of hepatitis B virus infections. Rheumatol Int 9, 167–173 (1989). https://doi.org/10.1007/BF00271875

Download citation

Key words

  • Hepatitis B virus
  • HBV, extrahepatic manifestations of
  • HBsAg
  • HBeAg
  • HBV, immune complexes of
  • HBV, immune response against